Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
INTELLIA THERAPE RG (NQ: NTLA)
21.71 USD  -0.23 (-1.05%)
Official Closing Price  /  Updated: 5:20 PM EDT, Apr 20, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 518,150
Open 21.80
Bid (Size) 21.50 (100)
Ask (Size) 22.60 (100)
Prev. Close 21.94
Today's Range 21.28 - 22.19
52wk Range 11.15 - 35.99
Shares Outstanding 43,091,922
Dividend Yield N/A
Performance
YTD
+0.93%
+0.93%
1 Month
-8.67%
-8.67%
3 Month
+8.82%
+8.82%
6 Month
-22.60%
-22.60%
1 Year
+53.00%
+53.00%
Top News
More News
Stocks Showing Improving Market Leadership: Intellia Therapeutics Earns 84 RS Rating
Intellia Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 69 to 84. Read More
from Investor's Business Daily
Intellia Therapeutics widens losses
Intellia Therapeutics Inc. (Nasdaq: NTLA) widened losses for the fourth quarter sending the stock price plunging $4.41 to close at $28.81.... Read More
from MarketMinute.com Stock News
More News
Read More
Stocks To Watch: Intellia Therapeutics Sees RS Rating Jump To 81
from Investor's Business Daily
Pre-Market Technical Scan on Biotech Equities -- INSYS Therapeutics, Intellia Therapeutics, Intercept Pharma, and Intra-Cellular Therapies
from PR Newswire
Gain in producer prices lifts markets
category Market News
from MarketMinute.com Market Updates
NTLA Crosses Above Key Moving Average Level
category Stocks
from Market News Video
Why Intellia Therapeutics, Inc. Stock Lost 19.2% in March
category NTLA
from Motley Fool
Analysts Expect 54% Gains Ahead For The Holdings of XBI
category ETFs
from ETF Channel
Biotechs Bounce Off Bottom On Novartis Deal But Fade Later In The Day
category Pharma/Biotech , Stocks / Equities , Healthcare
from Blogs - TalkMarkets
Oops! CRISPR Concerns Turn Out to be a Big Nothingburger
category EDIT , CRSP , NTLA
from Motley Fool
Mid-Afternoon Market Update: Intellia Therapeutics Slides Following Q4 Results; Arcadia Biosciences Shares Surge
category RFIL , RKDA , SIG , and 16 more.
from Benzinga
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
X